Skip to main content
Clinical Trials/IRCT20230204057318N4
IRCT20230204057318N4
Recruiting
Phase 3

Comparing the effect of prophylactic administration of fibrinogen, tranexamic acid, or simultaneous use of both on perioperative bleeding in patients undergoing radical cystectomy and investigating clinical outcomes in the intensive care unit: a randomized double-blind study

Shahid Beheshti University of Medical Sciences0 sites105 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Intraoperative radical cystectomy.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
105
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who are candidates for elective radical cystectomy surgery under general anesthesia with muscle relaxation and mechanical ventilation

Exclusion Criteria

  • Patient on anticoagulant agent
  • Having a known blood Abnormality or coagulopathy
  • Chronic liver disease
  • Chronic kidney disease with a serum creatinine level of \> 2 mg/dL
  • Preoperative plasma fibrinogen level of \=150 or \= 400 mg/dL
  • History of heart infarction, deep vein thrombosis, pulmonary embolism, stroke

Outcomes

Primary Outcomes

Not specified

Similar Trials